Loading…
Polygenic Risk Scores in Alzheimer’s Disease Genetics: Methodology, Applications, Inclusion, and Diversity
The success of genome-wide association studies (GWAS) completed in the last 15 years has reinforced a key fact: polygenic architecture makes a substantial contribution to variation of susceptibility to complex disease, including Alzheimer’s disease. One straight-forward way to capture this architect...
Saved in:
Published in: | Journal of Alzheimer's disease 2022-01, Vol.89 (1), p.1-12 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c383t-f97fd095a600062e01c076f2a028295600792445c4d29e3b0a89be56f6143e03 |
---|---|
cites | cdi_FETCH-LOGICAL-c383t-f97fd095a600062e01c076f2a028295600792445c4d29e3b0a89be56f6143e03 |
container_end_page | 12 |
container_issue | 1 |
container_start_page | 1 |
container_title | Journal of Alzheimer's disease |
container_volume | 89 |
creator | Clark, Kaylyn Leung, Yuk Yee Lee, Wan-Ping Voight, Benjamin Wang, Li-San |
description | The success of genome-wide association studies (GWAS) completed in the last 15 years has reinforced a key fact: polygenic architecture makes a substantial contribution to variation of susceptibility to complex disease, including Alzheimer’s disease. One straight-forward way to capture this architecture and predict which individuals in a population are most at risk is to calculate a polygenic risk score (PRS). This score aggregates the risk conferred across multiple genetic variants, ultimately representing an individual’s predicted genetic susceptibility for a disease. PRS have received increasing attention after having been successfully used in complex traits. This has brought with it renewed attention on new methods which improve the accuracy of risk prediction. While these applications are initially informative, their utility is far from equitable: the majority of PRS models use samples heavily if not entirely of individuals of European descent. This basic approach opens concerns of health equity if applied inaccurately to other population groups, or health disparity if we fail to use them at all. In this review we will examine the methods of calculating PRS and some of their previous uses in disease prediction. We also advocate for, with supporting scientific evidence, inclusion of data from diverse populations in these existing and future studies of population risk via PRS. |
doi_str_mv | 10.3233/JAD-220025 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2691459788</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.3233_JAD-220025</sage_id><sourcerecordid>2707921194</sourcerecordid><originalsourceid>FETCH-LOGICAL-c383t-f97fd095a600062e01c076f2a028295600792445c4d29e3b0a89be56f6143e03</originalsourceid><addsrcrecordid>eNptkc9OFEEQxjsGI4hefADTCQeI2dH-MzPdzW2zCEIwGuU-6e2pWRp6p5euGZP1xGv4ejwJTRY0IZ6qUvnVV1_qI-QdZx-lkPLT2fSoEIIxUb0gO1yrqtCG6a3cS60KoZXaJq8Rrxhjkhn1imzLSpeacbNDwvcY1gvovaM_PF7Tny4mQOp7Og2_L8EvId3d_kF65BEsAj2BHgbv8JB-heEytjHExXpCp6tV8M4OPvY4oae9CyPmfkJt3-bdX5DQD-s35GVnA8Lbx7pLLo4_X8y-FOffTk5n0_PCSS2HojOqa5mpbJ0d1wIYd0zVnbBMaGGqPFVGlGXlylYYkHNmtZlDVXc1LyUwuUsONrKrFG9GwKFZenQQgu0hjtiI2vCyMkrrjO49Q6_imPpsrhHq4QznpszUhw3lUkRM0DWr5Jc2rRvOmocImhxBs4kgw-8fJcf5Etq_6NPPM7C_AdAu4N-9_0jdA1rcjC8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2707921194</pqid></control><display><type>article</type><title>Polygenic Risk Scores in Alzheimer’s Disease Genetics: Methodology, Applications, Inclusion, and Diversity</title><source>SAGE:Jisc Collections:SAGE Journals Read and Publish 2023-2024:2025 extension (reading list)</source><creator>Clark, Kaylyn ; Leung, Yuk Yee ; Lee, Wan-Ping ; Voight, Benjamin ; Wang, Li-San</creator><creatorcontrib>Clark, Kaylyn ; Leung, Yuk Yee ; Lee, Wan-Ping ; Voight, Benjamin ; Wang, Li-San</creatorcontrib><description>The success of genome-wide association studies (GWAS) completed in the last 15 years has reinforced a key fact: polygenic architecture makes a substantial contribution to variation of susceptibility to complex disease, including Alzheimer’s disease. One straight-forward way to capture this architecture and predict which individuals in a population are most at risk is to calculate a polygenic risk score (PRS). This score aggregates the risk conferred across multiple genetic variants, ultimately representing an individual’s predicted genetic susceptibility for a disease. PRS have received increasing attention after having been successfully used in complex traits. This has brought with it renewed attention on new methods which improve the accuracy of risk prediction. While these applications are initially informative, their utility is far from equitable: the majority of PRS models use samples heavily if not entirely of individuals of European descent. This basic approach opens concerns of health equity if applied inaccurately to other population groups, or health disparity if we fail to use them at all. In this review we will examine the methods of calculating PRS and some of their previous uses in disease prediction. We also advocate for, with supporting scientific evidence, inclusion of data from diverse populations in these existing and future studies of population risk via PRS.</description><identifier>ISSN: 1387-2877</identifier><identifier>EISSN: 1875-8908</identifier><identifier>DOI: 10.3233/JAD-220025</identifier><identifier>PMID: 35848019</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Alzheimer Disease - genetics ; Alzheimer's disease ; Genetic diversity ; Genetic Predisposition to Disease - genetics ; Genetic variance ; Genetics ; Genome-wide association studies ; Genome-Wide Association Study ; Genomes ; Humans ; Multifactorial Inheritance - genetics ; Neurodegenerative diseases ; Polygenic inheritance ; Population studies ; Risk ; Risk Factors</subject><ispartof>Journal of Alzheimer's disease, 2022-01, Vol.89 (1), p.1-12</ispartof><rights>2022 – The authors. Published by IOS Press</rights><rights>Copyright IOS Press BV 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c383t-f97fd095a600062e01c076f2a028295600792445c4d29e3b0a89be56f6143e03</citedby><cites>FETCH-LOGICAL-c383t-f97fd095a600062e01c076f2a028295600792445c4d29e3b0a89be56f6143e03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>313,314,776,780,788,27899,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35848019$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Clark, Kaylyn</creatorcontrib><creatorcontrib>Leung, Yuk Yee</creatorcontrib><creatorcontrib>Lee, Wan-Ping</creatorcontrib><creatorcontrib>Voight, Benjamin</creatorcontrib><creatorcontrib>Wang, Li-San</creatorcontrib><title>Polygenic Risk Scores in Alzheimer’s Disease Genetics: Methodology, Applications, Inclusion, and Diversity</title><title>Journal of Alzheimer's disease</title><addtitle>J Alzheimers Dis</addtitle><description>The success of genome-wide association studies (GWAS) completed in the last 15 years has reinforced a key fact: polygenic architecture makes a substantial contribution to variation of susceptibility to complex disease, including Alzheimer’s disease. One straight-forward way to capture this architecture and predict which individuals in a population are most at risk is to calculate a polygenic risk score (PRS). This score aggregates the risk conferred across multiple genetic variants, ultimately representing an individual’s predicted genetic susceptibility for a disease. PRS have received increasing attention after having been successfully used in complex traits. This has brought with it renewed attention on new methods which improve the accuracy of risk prediction. While these applications are initially informative, their utility is far from equitable: the majority of PRS models use samples heavily if not entirely of individuals of European descent. This basic approach opens concerns of health equity if applied inaccurately to other population groups, or health disparity if we fail to use them at all. In this review we will examine the methods of calculating PRS and some of their previous uses in disease prediction. We also advocate for, with supporting scientific evidence, inclusion of data from diverse populations in these existing and future studies of population risk via PRS.</description><subject>Alzheimer Disease - genetics</subject><subject>Alzheimer's disease</subject><subject>Genetic diversity</subject><subject>Genetic Predisposition to Disease - genetics</subject><subject>Genetic variance</subject><subject>Genetics</subject><subject>Genome-wide association studies</subject><subject>Genome-Wide Association Study</subject><subject>Genomes</subject><subject>Humans</subject><subject>Multifactorial Inheritance - genetics</subject><subject>Neurodegenerative diseases</subject><subject>Polygenic inheritance</subject><subject>Population studies</subject><subject>Risk</subject><subject>Risk Factors</subject><issn>1387-2877</issn><issn>1875-8908</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>AFRWT</sourceid><recordid>eNptkc9OFEEQxjsGI4hefADTCQeI2dH-MzPdzW2zCEIwGuU-6e2pWRp6p5euGZP1xGv4ejwJTRY0IZ6qUvnVV1_qI-QdZx-lkPLT2fSoEIIxUb0gO1yrqtCG6a3cS60KoZXaJq8Rrxhjkhn1imzLSpeacbNDwvcY1gvovaM_PF7Tny4mQOp7Og2_L8EvId3d_kF65BEsAj2BHgbv8JB-heEytjHExXpCp6tV8M4OPvY4oae9CyPmfkJt3-bdX5DQD-s35GVnA8Lbx7pLLo4_X8y-FOffTk5n0_PCSS2HojOqa5mpbJ0d1wIYd0zVnbBMaGGqPFVGlGXlylYYkHNmtZlDVXc1LyUwuUsONrKrFG9GwKFZenQQgu0hjtiI2vCyMkrrjO49Q6_imPpsrhHq4QznpszUhw3lUkRM0DWr5Jc2rRvOmocImhxBs4kgw-8fJcf5Etq_6NPPM7C_AdAu4N-9_0jdA1rcjC8</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>Clark, Kaylyn</creator><creator>Leung, Yuk Yee</creator><creator>Lee, Wan-Ping</creator><creator>Voight, Benjamin</creator><creator>Wang, Li-San</creator><general>SAGE Publications</general><general>IOS Press BV</general><scope>AFRWT</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20220101</creationdate><title>Polygenic Risk Scores in Alzheimer’s Disease Genetics: Methodology, Applications, Inclusion, and Diversity</title><author>Clark, Kaylyn ; Leung, Yuk Yee ; Lee, Wan-Ping ; Voight, Benjamin ; Wang, Li-San</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c383t-f97fd095a600062e01c076f2a028295600792445c4d29e3b0a89be56f6143e03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Alzheimer Disease - genetics</topic><topic>Alzheimer's disease</topic><topic>Genetic diversity</topic><topic>Genetic Predisposition to Disease - genetics</topic><topic>Genetic variance</topic><topic>Genetics</topic><topic>Genome-wide association studies</topic><topic>Genome-Wide Association Study</topic><topic>Genomes</topic><topic>Humans</topic><topic>Multifactorial Inheritance - genetics</topic><topic>Neurodegenerative diseases</topic><topic>Polygenic inheritance</topic><topic>Population studies</topic><topic>Risk</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Clark, Kaylyn</creatorcontrib><creatorcontrib>Leung, Yuk Yee</creatorcontrib><creatorcontrib>Lee, Wan-Ping</creatorcontrib><creatorcontrib>Voight, Benjamin</creatorcontrib><creatorcontrib>Wang, Li-San</creatorcontrib><collection>SAGE Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of Alzheimer's disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Clark, Kaylyn</au><au>Leung, Yuk Yee</au><au>Lee, Wan-Ping</au><au>Voight, Benjamin</au><au>Wang, Li-San</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Polygenic Risk Scores in Alzheimer’s Disease Genetics: Methodology, Applications, Inclusion, and Diversity</atitle><jtitle>Journal of Alzheimer's disease</jtitle><addtitle>J Alzheimers Dis</addtitle><date>2022-01-01</date><risdate>2022</risdate><volume>89</volume><issue>1</issue><spage>1</spage><epage>12</epage><pages>1-12</pages><issn>1387-2877</issn><eissn>1875-8908</eissn><abstract>The success of genome-wide association studies (GWAS) completed in the last 15 years has reinforced a key fact: polygenic architecture makes a substantial contribution to variation of susceptibility to complex disease, including Alzheimer’s disease. One straight-forward way to capture this architecture and predict which individuals in a population are most at risk is to calculate a polygenic risk score (PRS). This score aggregates the risk conferred across multiple genetic variants, ultimately representing an individual’s predicted genetic susceptibility for a disease. PRS have received increasing attention after having been successfully used in complex traits. This has brought with it renewed attention on new methods which improve the accuracy of risk prediction. While these applications are initially informative, their utility is far from equitable: the majority of PRS models use samples heavily if not entirely of individuals of European descent. This basic approach opens concerns of health equity if applied inaccurately to other population groups, or health disparity if we fail to use them at all. In this review we will examine the methods of calculating PRS and some of their previous uses in disease prediction. We also advocate for, with supporting scientific evidence, inclusion of data from diverse populations in these existing and future studies of population risk via PRS.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>35848019</pmid><doi>10.3233/JAD-220025</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1387-2877 |
ispartof | Journal of Alzheimer's disease, 2022-01, Vol.89 (1), p.1-12 |
issn | 1387-2877 1875-8908 |
language | eng |
recordid | cdi_proquest_miscellaneous_2691459788 |
source | SAGE:Jisc Collections:SAGE Journals Read and Publish 2023-2024:2025 extension (reading list) |
subjects | Alzheimer Disease - genetics Alzheimer's disease Genetic diversity Genetic Predisposition to Disease - genetics Genetic variance Genetics Genome-wide association studies Genome-Wide Association Study Genomes Humans Multifactorial Inheritance - genetics Neurodegenerative diseases Polygenic inheritance Population studies Risk Risk Factors |
title | Polygenic Risk Scores in Alzheimer’s Disease Genetics: Methodology, Applications, Inclusion, and Diversity |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T23%3A50%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Polygenic%20Risk%20Scores%20in%20Alzheimer%E2%80%99s%20Disease%20Genetics:%20Methodology,%20Applications,%20Inclusion,%20and%20Diversity&rft.jtitle=Journal%20of%20Alzheimer's%20disease&rft.au=Clark,%20Kaylyn&rft.date=2022-01-01&rft.volume=89&rft.issue=1&rft.spage=1&rft.epage=12&rft.pages=1-12&rft.issn=1387-2877&rft.eissn=1875-8908&rft_id=info:doi/10.3233/JAD-220025&rft_dat=%3Cproquest_cross%3E2707921194%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c383t-f97fd095a600062e01c076f2a028295600792445c4d29e3b0a89be56f6143e03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2707921194&rft_id=info:pmid/35848019&rft_sage_id=10.3233_JAD-220025&rfr_iscdi=true |